1. Home
  2. OFLX vs EOLS Comparison

OFLX vs EOLS Comparison

Compare OFLX & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Omega Flex Inc.

OFLX

Omega Flex Inc.

N/A

Current Price

$29.01

Market Cap

333.0M

Sector

Industrials

ML Signal

N/A

Logo Evolus Inc.

EOLS

Evolus Inc.

N/A

Current Price

$5.27

Market Cap

304.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OFLX
EOLS
Founded
1975
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
333.0M
304.0M
IPO Year
2005
2018

Fundamental Metrics

Financial Performance
Metric
OFLX
EOLS
Price
$29.01
$5.27
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$15.50
AVG Volume (30 Days)
31.8K
1.4M
Earning Date
06-12-2026
05-21-2026
Dividend Yield
4.55%
N/A
EPS Growth
N/A
1.23
EPS
1.13
N/A
Revenue
$101,681,000.00
$297,176,000.00
Revenue This Year
N/A
$14.41
Revenue Next Year
N/A
$16.96
P/E Ratio
$26.50
N/A
Revenue Growth
N/A
11.61
52 Week Low
$25.58
$4.09
52 Week High
$41.74
$13.66

Technical Indicators

Market Signals
Indicator
OFLX
EOLS
Relative Strength Index (RSI) 29.81 58.52
Support Level $26.32 $4.74
Resistance Level $29.54 $7.29
Average True Range (ATR) 1.91 0.31
MACD -1.07 0.17
Stochastic Oscillator 22.16 54.65

Price Performance

Historical Comparison
OFLX
EOLS

About OFLX Omega Flex Inc.

Omega Flex Inc is a manufacturer of flexible metal hoses, which is used in a variety of ways to carry gases and liquids within their particular applications. Omega sells its products under the TracPipe, CounterStrike, DoubleTrac, DEF-Trac and MediTrac brands. It serves various markets which include construction, manufacturing, transportation, petrochemical, pharmaceutical, and other industries. Geographically Omega Flex, Inc operates in the United States. The company derives revenues from the manufacture and sale of flexible metal hose and accessories.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: